Forecast Ledgerinterventional psychiatry and psychedelic medicineQuoted, dated predictions scored against public outcomes under one written method. Every score links to the words, the rule and the evidence.

Not admitted · Commitment (own venture)

Rules 1.1.0 · as of 14 Sep 2026

Quote

Commitment (own venture)

“Changemark's background ensures the study will be conducted with the highest scientific standards to deliver the evidence that Veterans and their healthcare providers need.”
· MAPS Partners with Changemark to Advance Cannabis PTSD Research for Veterans · article

MAPS names Changemark as CRO for the MJP2 Phase 2 study of inhaled cannabis for PTSD in veterans, funded by a $12.9M Michigan grant. Doblin forecasts the conduct and evidentiary output of the study.

The forecaster's own organization can make the outcome happen by its own decision: clinic openings, product launches, hires, trial starts, filings by their own company. Listed in the commitments table, never scored.